Hologic, Inc. develops and supplies a range of medical products focused primarily on women's health. Its revenue comes from four main segments: Diagnostics (approximately 40%), Breast Health (30%), GYN Surgical (20%), and Skeletal Health (10%). Key products include molecular diagnostic assays, breast imaging systems, and surgical products for gynecological procedures. Factors supporting Hologic's endurance include a strong focus on innovation and a growing demand for women's health services, while potential limitations include regulatory challenges and competition in the medical device market.
—
Hologic, Inc. develops and supplies a range of medical products focused primarily on women's health. Its revenue comes from four main segments: Diagnostics (approximately 40%), Breast Health (30%), GYN Surgical (20%), and Skeletal Health (10%). Key products include molecular diagnostic assays, breast imaging systems, and surgical products for gynecological procedures. Factors supporting Hologic's endurance include a strong focus on innovation and a growing demand for women's health services, while potential limitations include regulatory challenges and competition in the medical device market.
—
Daily adjusted close
Hologic, Inc. develops and supplies a range of medical products focused primarily on women's health. Its revenue comes from four main segments: Diagnostics (approximately 40%), Breast Health (30%), GYN Surgical (20%), and Skeletal Health (10%). Key products include molecular diagnostic assays, breast imaging systems, and surgical products for gynecological procedures. Factors supporting Hologic's endurance include a strong focus on innovation and a growing demand for women's health services, while potential limitations include regulatory challenges and competition in the medical device market.